LEADER 03589nam 22005055 450 001 9910349266503321 005 20200702160750.0 010 $a94-007-7743-4 024 7 $a10.1007/978-94-007-7743-9 035 $a(CKB)3710000000580395 035 $a(DE-He213)978-94-007-7743-9 035 $a(PPN)242975658 035 $a(EXLCZ)993710000000580395 100 $a20190617d2020 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiomarkers in Kidney Disease$b[electronic resource] /$fedited by Vinood B. Patel, Victor R. Preedy 210 1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2020. 215 $a1 online resource (Approx. 800 p. 50 illus.) 225 1 $aBiomarkers in Disease: Methods, Discoveries and Applications,$x2542-3657 327 $aEndocrinology -- Addictions -- Immunology -- Genetics. 330 $aIn the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel markers of disease relating to autoimmune disorders, cancers, endocrine diseases, genetic disorders, sensory damage, intestinal diseases etc. In many instances these developments have gone hand in hand with the discovery of biomarkers elucidated via traditional or conventional methods, such as histopathology or clinical biochemistry. Together with microprocessor-based data analysis, advanced statistics and bioinformatics these markers have been used to identify individuals with active disease or pathology as well as those who are refractory or have distinguishing pathologies. New analytical methods that have been used to identify markers of disease and is suggested that there may be as many as 40 different platforms. Unfortunately techniques and methods have not been readily transferable to other disease states and sometimes diagnosis still relies on single analytes rather than a cohort of markers. There is thus a demand for a comprehensive and focused evidenced-based text and scientific literature that addresses these issues. Hence the formulation of Biomarkers in Disease. The series covers a wide number of areas including for example, nutrition, cancer, endocrinology, cardiology, addictions, immunology, birth defects, genetics, and so on. The chapters are written by national or international experts and specialists. 410 0$aBiomarkers in Disease: Methods, Discoveries and Applications,$x2542-3657 606 $aCancer research 606 $aOncology   606 $aPharmacology 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 615 0$aCancer research. 615 0$aOncology  . 615 0$aPharmacology. 615 14$aCancer Research. 615 24$aOncology. 615 24$aPharmacology/Toxicology. 676 $a614.5999 702 $aPatel$b Vinood B$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPreedy$b Victor R$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910349266503321 996 $aBiomarkers in Kidney Disease$92496663 997 $aUNINA